Kynurenic acid in schizophrenia: a systematic review and meta-analysis E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ... Schizophrenia bulletin 43 (4), 764-777, 2017 | 213 | 2017 |
The potential role of dopamine D3 receptor neurotransmission in cognition S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ... European Neuropsychopharmacology 23 (8), 799-813, 2013 | 205 | 2013 |
Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ... Frontiers in psychiatry 9, 622, 2018 | 191 | 2018 |
Glutamate-mediated excitotoxicity in schizophrenia: a review E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ... European Neuropsychopharmacology 24 (10), 1591-1605, 2014 | 180 | 2014 |
Individual determinants of COVID-19 vaccine hesitancy P Gerretsen, J Kim, F Caravaggio, L Quilty, M Sanches, S Wells, ... PloS one 16 (11), e0258462, 2021 | 154 | 2021 |
Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study Y Iwata, S Nakajima, E Plitman, F Caravaggio, J Kim, P Shah, W Mar, ... Biological psychiatry 85 (7), 596-605, 2019 | 112 | 2019 |
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials Y Iwata, S Nakajima, T Suzuki, RSE Keefe, E Plitman, JK Chung, ... Molecular psychiatry 20 (10), 1151-1160, 2015 | 108 | 2015 |
Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia S Nakajima, H Takeuchi, E Plitman, G Fervaha, P Gerretsen, ... Schizophrenia research 164 (1-3), 164-175, 2015 | 104 | 2015 |
Insight and medication adherence in schizophrenia: An analysis of the CATIE trial J Kim, M Ozzoude, S Nakajima, P Shah, F Caravaggio, Y Iwata, ... Neuropharmacology 168, 107634, 2020 | 94 | 2020 |
Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/3 receptor occupancy study A Graff-Guerrero, TK Rajji, BH Mulsant, S Nakajima, F Caravaggio, ... JAMA psychiatry 72 (9), 927-934, 2015 | 88 | 2015 |
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review P Shah, Y Iwata, E Plitman, EE Brown, F Caravaggio, J Kim, S Nakajima, ... Psychiatry research 268, 114-122, 2018 | 80 | 2018 |
Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans F Caravaggio, C Borlido, M Hahn, Z Feng, G Fervaha, P Gerretsen, ... International Journal of Neuropsychopharmacology 18 (7), pyv014, 2015 | 77 | 2015 |
Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index F Caravaggio, S Raitsin, P Gerretsen, S Nakajima, A Wilson, ... Biological psychiatry 77 (2), 196-202, 2015 | 68 | 2015 |
Lifetime history of depression predicts increased amyloid-β accumulation in patients with mild cognitive impairment JK Chung, E Plitman, S Nakajima, TW Chow, MM Chakravarty, ... Journal of Alzheimer's Disease 45 (3), 907-919, 2015 | 66 | 2015 |
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies Y Iwata, S Nakajima, E Plitman, Y Mihashi, F Caravaggio, JK Chung, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 86, 340-352, 2018 | 60 | 2018 |
The VAGUS insight into psychosis scale–self-report and clinician-rated versions P Gerretsen, G Remington, C Borlido, L Quilty, S Hassan, G Polsinelli, ... Psychiatry research 220 (3), 1084-1089, 2014 | 54 | 2014 |
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment M Wada, Y Noda, Y Iwata, S Tsugawa, K Yoshida, H Tani, Y Hirano, ... Molecular Psychiatry 27 (7), 2950-2967, 2022 | 53 | 2022 |
A meta-analysis of transcranial direct current stimulation for schizophrenia:“Is more better?” J Kim, Y Iwata, E Plitman, F Caravaggio, JK Chung, P Shah, ... Journal of psychiatric research 110, 117-126, 2019 | 53 | 2019 |
Cortical amyloid β deposition and current depressive symptoms in Alzheimer disease and mild cognitive impairment JK Chung, E Plitman, S Nakajima, MM Chakravarty, F Caravaggio, ... Journal of geriatric psychiatry and neurology 29 (3), 149-159, 2016 | 50 | 2016 |
Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairment JK Chung, E Plitman, S Nakajima, MM Chakravarty, F Caravaggio, ... Journal of Alzheimer's Disease 49 (3), 743-754, 2016 | 48 | 2016 |